February 3, 2020 10:12 AM EST

Revolution Medicines shoots for $150 million IPO; Novartis vet heads to Boston Pharma

→ A week after BlackDiamond Therapeutics set the early bar for 2020 IPOs, Revolution Medicines has priced

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Rev­o­lu­tion Med­i­cines shoots for $150 mil­lion IPO; No­var­tis vet heads to Boston Phar­ma